Activation of NF-E2-related factor-2 reverses biochemical dysfunction of endothelial cells induced by hyperglycemia linked to vascular disease

Xue, M, Qian, Q, Adaikalakoteswari, A ORCID: https://orcid.org/0000-0003-2974-3388, Rabbani, N, Babaei-Jadidi, R and Thornalley, PJ, 2008. Activation of NF-E2-related factor-2 reverses biochemical dysfunction of endothelial cells induced by hyperglycemia linked to vascular disease. Diabetes, 57 (10), pp. 2809-2817. ISSN 0012-1797

Preview

Text PubSub10957_Adaikalakoteswari.pdf - Published version Download (335kB) | Preview

Abstract

Objecive: Sulforaphane is an activator of transcription factor NF-E2–related factor-2 (nrf2) that regulates gene expression through the promoter antioxidant response element (ARE). Nrf2 regulates the transcription of a battery of protective and metabolic enzymes. The aim of this study was to assess whether activation of nrf2 by sulforaphane in human microvascular endothelial cells prevents metabolic dysfunction in hyperglycemia.

Research design and methods: Human microvascular HMEC-1 endothelial cells were incubated in low and high glucose concentrations (5 and 30 mmol/l, respectively), and activation of nrf2 was assessed by nuclear translocation. The effects of sulforaphane on multiple pathways of biochemical dysfunction, increased reactive oxygen species (ROS) formation, hexosamine pathway, protein kinase C (PKC) pathway, and increased formation of methylglyoxal were assessed.

Results: Activation of nrf2 by sulforaphane induced nuclear translocation of nrf2 and increased ARE-linked gene expression, for example, three- to fivefold increased expression of transketolase and glutathione reductase. Hyperglycemia increased the formation of ROS—an effect linked to mitochondrial dysfunction and prevented by sulforaphane. ROS formation was increased further by knockdown of nrf2 and transketolase expression. This also abolished the counteracting effect of sulforaphane, suggesting mediation by nrf2 and related increase of transketolase expression. Sulforaphane also prevented hyperglycemia-induced activation of the hexosamine and PKC pathways and prevented increased cellular accumulation and excretion of the glycating agent methylglyoxal.

Conclusions: We conclude that activation of nrf2 may prevent biochemical dysfunction and related functional responses of endothelial cells induced by hyperglycemia in which increased expression of transketolase has a pivotal role.

Item Type:	Journal article
Publication Title:	Diabetes
Creators:	Xue, M., Qian, Q., Adaikalakoteswari, A., Rabbani, N., Babaei-Jadidi, R. and Thornalley, P.J.
Publisher:	American Diabetes Association
Date:	October 2008
Volume:	57
Number:	10
ISSN:	0012-1797
Identifiers:	Number Type 10.2337/db06-1003 DOI
Divisions:	Schools > School of Science and Technology
Record created by:	Linda Sullivan
Date Added:	04 May 2018 14:00
Last Modified:	04 May 2018 14:02
URI:	https://irep.ntu.ac.uk/id/eprint/33445

Actions (login required)

Edit View

Statistics

Views

Downloads